Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Upcoming Portfolio Shift for a Major Global Equity ETF

Robert Sasse by Robert Sasse
January 29, 2026
in Analysis, ETF, Market Commentary
0
MSCI World ETF Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Investors tracking developed markets worldwide are turning their attention to an imminent index rebalancing event. The iShares MSCI World ETF (URTH), managed by BlackRock, is set to reflect the quarterly review results announced by MSCI on February 10, 2026, with changes taking effect March 2, 2026. This adjustment is anticipated to bring notable shifts in the fund’s country, sector, and individual security allocations.

The fund provides exposure to a vast basket of over 1,300 equities from developed nations. As global equity markets continue their ascent into early 2026, this rebalancing presents a key moment for the portfolio.

Fund Profile and Investor Appeal

Boasting approximately $7 billion in assets under management, URTH is a established choice for diversified equity exposure, carrying an expense ratio of 0.24%. Investor demand remains robust, with net inflows over a one-year period reaching about $1.52 billion. A longer three-year view shows net inflows of roughly $2.29 billion, and when combined with market appreciation, the fund’s total assets grew by approximately $4.29 billion in that span.

The ETF faces competition from products like the SPDR MSCI World StrategicFactors ETF and the JPMorgan Diversified Return Global Equity ETF. A distinguishing feature of URTH is its comprehensive inclusion of North American markets, offering full access to the developed world.

Current Holdings and Sector Concentration

Mirroring the market-capitalization-weighted methodology of the underlying MSCI World Index, the portfolio’s structure shows significant concentration in mega-cap technology firms. As of the end of January 2026, the fund held around 1,322 positions.

Should investors sell immediately? Or is it worth buying MSCI World ETF?

Key Portfolio Characteristics:
* The top 10 holdings account for an estimated 26-27% of the fund’s assets.
* The technology sector commands a dominant 28% weighting.
* Financial services follow at 17%, with industrials at 11%.

NVIDIA leads the holdings with a weight between 5.3% and 5.5%, followed by Apple (4.4-4.9%) and Microsoft (3.8-4.1%). Amazon and Alphabet complete the top five. While this concentration is lower than in focused strategies, the performance of these large tech names substantially influences the fund’s returns.

Market Context and Analyst Outlook

The rebalancing occurs against a backdrop of strong global market performance. Schroders noted that worldwide equities hit fresh all-time highs in early 2026, with the ongoing U.S. bull market ranking as the second-longest and second-strongest in at least a century.

In January 2026, researchers at Goldman Sachs projected roughly 11% returns for global stocks over the subsequent twelve months. They suggested that driving this growth would be corporate earnings expansion rather than multiple expansion. Their analysis also highlighted that geographic diversification proved advantageous in 2025, with European and emerging market equities outperforming U.S. stocks on a dollar-adjusted basis.

The upcoming index adjustment on March 2 may recalibrate the fund’s weightings. Its future trajectory will be shaped by how the index components and broader global markets evolve in the coming weeks.

Ad

MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from February 7 delivers the answer:

The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

MSCI World ETF: Buy or sell? Read more here...

Tags: MSCI World ETF
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Next Post
Aventis Energy Stock

Key Catalysts on the Horizon for Aventis Energy

DeFi Technologies Stock

Deadline Approaches for Lead Plaintiff in DeFi Technologies Securities Class Action

European Lithium Stock

European Lithium Broadens Horizons with Strategic Acquisition and Capital Boost

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com